@prefix orcid: . @prefix this: . @prefix sub: . @prefix np: . @prefix rdf: . @prefix xsd: . @prefix rdfs: . @prefix ns2: . @prefix ns1: . @prefix prov: . @prefix ns3: . @prefix npx: . sub:Head { this: np:hasAssertion sub:assertion; np:hasProvenance sub:provenance; np:hasPublicationInfo sub:pubInfo; a np:Nanopublication . } sub:assertion { sub:assertion prov:wasGeneratedBy "S&T TWOC project version 1" . sub:version prov:value "1"^^xsd:integer . rdf:object ns1:C0011777 "dexamethasone"; ns1:C0178602 "doses"; ns1:C0205250 "higher" . rdf:predicate ns2:TRIPLE_UID:1jnziuot-TRIPLE-ABSTRACT-13 "result" . rdf:subject ns1:C0009566 "complications"; ns1:C0011777 "dexamethasone"; ns1:C0163712 "related"; ns1:C0439849 "related"; ns1:C0445223 "related"; ns1:C0802632 "complications"; ns1:C1704787 "related" . rdfs:Triple-UID ns3:TRIPLE_UID:1jnziuot-TRIPLE-ABSTRACT-13 "1jnziuot-TRIPLE-ABSTRACT-13" . rdfs:sentence rdfs:label "In order to increase the therapeutic efficacy of dexamethasone in COVID-19 patients, while minimizing dexamethasone-related complications that could result from using higher doses of dexamethasone, we applied a chemocentric informatics approach to identify combination therapies." . rdfs:triple rdfs:label "dexamethasone - related complications result from using higher doses of dexamethasone" . } sub:provenance { sub:assertion prov:generatedAtTime "2021-07-25T21:46:28.097567"^^xsd:dateTime . } sub:pubInfo { sub:sig npx:hasAlgorithm "RSA"; npx:hasPublicKey "MIGfMA0GCSqGSIb3DQEBAQUAA4GNADCBiQKBgQCSLeezU8JYlBsrgXOGXX4fxOq4oydsMzMK1CN0Rez2OEd2IYk18R4DetcZXwGhN3Pil7qcgNkiGvTirJXIo8zHl7jVehs19EdYtrttCKEaXRzWIr4LuCrfGedkvonEMWqR8e1GdQsLgEEyM50BD6Qw+srQt9ozcqf/9wG2MAMX9QIDAQAB"; npx:hasSignature "fSYAamhjJuohHhse45kJNgX8J4N1wrRjXF3WiJLIuBl5Vu+MTiKKiUwho36KmhZuRzEXW1jJVlv/JJIEExMj9kDGMLiVlD3UdAwzJ/UuhW/0bIxr37k+22+7s5tTikNb/jcyNzvFehXbvnxF1joxNd82byJpuvlHCiQr468nJqI="; npx:hasSignatureTarget this: . this: prov:generatedAtTime "2021-07-25T21:46:28.097567"^^xsd:dateTime; prov:wasAttributedTo orcid:0000-0002-8954-0470 . }